Kurtulus GOKDUMAN, Ph.D.
SCIENTIFIC DIRECTOR, TOXICOLOGY
- Phone
- Email
- Website
-
Address Info308 Faneuil St, Boston, MA 02135, USA
-
Certificates:FDA,OECD
PERSONAL EXPERIENCE
Dr. Kurtulus Gokduman brings over a decade of advanced translational research and industrial expertise to his role as Scientific Director, Toxicology. He oversees our scientific strategy, ensuring the highest standards of safety, quality, and regulatory compliance for cutting-edge technologies. His extensive experience spans biological, toxicological, and clinical evaluations as well as regulatory compliance, backed by pioneering postdoctoral research at Harvard Medical School, Boston, USA.
Key Expertise:
- World-Class Research: A recognized expert in nanotoxicology and liver models, he completed two research fellowships at Harvard Medical School and Massachusetts General Hospital, Boston, USA, pioneering 3D microfluidic liver models to evaluate nanotoxicological safety profiles, resulting in highly cited publications in prestigious Q1 journals.
- Academic Excellence: He holds a B.Sc. in Biology, M.Sc. in Biotechnology (focused on dental bleaching toxicology), and Ph.D. in Biotechnology (focused on food toxicology as well as biocompatible delivery of anti-cancer compounds using nanomedicine approaches) from Middle East Technical University, Ankara, Turkey. He was awarded the rank of Associate Professor of Biology in 2021.
- Regulatory Mastery: Driven to meet industry needs for consultancy, reporting, and filing services on scientific, technical, quality, and regulatory matters, he founded BIOMEDRIC LLC, leading over 15 major projects to author critical technical files approved by the USA and EU regulatory authorities, including end-to-end regulatory strategy as well as biological, toxicological, and clinical evaluations.
- Global Leadership: He serves as an expert project evaluator for the European Union’s prestigious Marie Skłodowska-Curie Actions Postdoctoral Fellowships program and as an expert for monitoring (technical reviews) of the projects funded under the European Union’s prestigious EIC Accelerator program; additionally, he serves as a reviewer for top-tier Q1 scientific journals.
Dr. Kurtulus Gokduman’s deep integration of academic innovation, rigorous industrial expertise, and global leadership qualities, in which roles he actively applies biological, toxicological, and clinical evaluation perspectives, ensures our clients receive gold-standard scientific oversight from preclinical development to global market approval.